Neogenomics (NEO) Invested Capital (2010 - 2020)

Neogenomics (NEO) has 11 years of Invested Capital data on file, last reported at $5.0 million in Q1 2020.

• Quarterly Invested Capital fell 36.49% year-over-year to $5.0 million in Q1 2020, while the trailing twelve-month figure through Dec 2020 was $5.0 million (down 81.98% YoY) and the FY2019 annual result came in at $8.6 million, down 25.26% from the prior year.
• Invested Capital retreated to $5.0 million in Q1 2020, from $8.6 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $13.3 million in Q3 2018 to a low of $596000.0 in Q1 2016.
• A 5-year average of $6.7 million and a median of $6.2 million in 2019 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2016 — Invested Capital plunged 57.72% — and 2017, when it soared 1382.21%.
• Tracing NEO's Invested Capital over 5 years: stood at $3.8 million in 2016, then jumped by 181.12% to $10.5 million in 2017, then rose by 9.54% to $11.5 million in 2018, then dropped by 25.26% to $8.6 million in 2019, then slumped by 42.07% to $5.0 million in 2020.
• The last three Invested Capital figures came in at $5.0 million (Q1 2020), $8.6 million (Q4 2019), and $6.2 million (Q3 2019), per Business Quant data.